Hannani, D., Vétizou, M., Enot, D., Rusakiewicz, S., Chaput, N., Klatzmann, D., . . . Zitvogel, L. (2015). Anticancer immunotherapy by CTLA-4 blockade: Obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res.
Chicago Style CitationHannani, Dalil, et al. "Anticancer Immunotherapy By CTLA-4 Blockade: Obligatory Contribution of IL-2 Receptors and Negative Prognostic Impact of Soluble CD25." Cell Res 2015.
MLA CitationHannani, Dalil, et al. "Anticancer Immunotherapy By CTLA-4 Blockade: Obligatory Contribution of IL-2 Receptors and Negative Prognostic Impact of Soluble CD25." Cell Res 2015.
Warning: These citations may not always be 100% accurate.